TF and Alzheimer disease: Both CR- and TF-treated groups were able to reduce MMP activity by ~95% when treated for 30 s or 1 h irrespective of the dentin collagen type (p > 0.05), except for CR- and TF-treated natural collagen and CR-treated AD for 30 s, which reduced MMP activity by ~90% and ~70%, respectively.